TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $51,318,000 | -9.7% | 5,290,481 | 0.0% | 0.82% | -3.9% |
Q1 2021 | $56,820,000 | -27.0% | 5,290,481 | 0.0% | 0.86% | -21.2% |
Q4 2020 | $77,823,000 | -11.1% | 5,290,481 | -14.2% | 1.09% | -32.1% |
Q3 2020 | $87,572,000 | +75.6% | 6,162,694 | 0.0% | 1.60% | +64.8% |
Q2 2020 | $49,856,000 | +94.0% | 6,162,694 | -3.1% | 0.97% | +19.7% |
Q1 2020 | $25,700,000 | – | 6,361,446 | – | 0.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Anson Funds Management LP | 174,174 | $298,000 | 0.17% |
Matrix Capital Management Company, LP | 2,288,560 | $3,913,000 | 0.13% |
Samsara BioCapital, LLC | 71,619 | $122,000 | 0.12% |
NEA Management Company, LLC | 1,250,000 | $2,138,000 | 0.08% |
Tekla Capital Management LLC | 446,099 | $763,000 | 0.03% |
PLATINUM INVESTMENT MANAGEMENT LTD | 175,339 | $306,000 | 0.01% |
Artal Group S.A. | 150,000 | $257,000 | 0.01% |
Baker Brothers Advisors | 505,262 | $864,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 20,044 | $34,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 57,055 | $98,000 | 0.00% |